ADVANCE CANINE CANCER RESEARCH—YOUR EXPERTISE MATTERS

Canine urinary bladder cancer impacts thousands of dogs each year, representing about 2% of all canine cancers. The most common form, urothelial carcinoma (UC), is highly invasive and carries a guarded prognosis—affecting not only the health of dogs but also the well-being of their families. While 14 breeds have been identified as higher risk, UC can occur in any breed. Unfortunately, many cases are diagnosed late, often involving the trigone and urethra, making treatment challenging.

We need your help to change this

Critical gaps remain in our understanding of UC pathophysiology. Expanded research is essential to develop better strategies for prevention, early detection, and treatment. Biobanks play a vital role by providing high-quality tissue samples for groundbreaking studies.

How You Can Contribute:

• Recruit cases and collect samples during routine diagnostic workups.
• Receive a sample kit with clear instructions—we make it simple.
• Shipping and reagents are covered by the consortium.

Your participation will accelerate discoveries that benefit both veterinary and human medicine. Together, we can transform outcomes for dogs and their families.

Request your kits now!

Interested or have questions? Contact us at: [email protected]

CLINICAL TRIALS FOR CANINE BLADDER CANCER

Help Advance Veterinary Oncology Research

If you have patients diagnosed with bladder cancer — or belong to high-risk breeds — you can play a vital role in advancing cancer care. Clinical trials provide access to innovative therapies while contributing to research that benefits dogs everywhere.

Why Refer Patients?

• Access cutting-edge treatments
• Contribute to life-saving research
• Shape the future of veterinary oncology

If you have a patient who may qualify, go to the Clinical Trials section for details and eligibility.